Factors Associated With Major Bleeding Events in AFib Patients Treated With Rivaroxaban
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Factors Associated With Major Bleeding Events: Insights From the Rivaroxaban Once-Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
J Am Coll Cardiol 2013 Nov 21;[EPub Ahead of Print], SG Goodman, DM Wojdyla, JP Piccini, HD White, JF Paolini, CC Nessel, SD Berkowitz, KW Mahaffey, MR Patel, MW Sherwood, RC Becker, JL Halperin, W Hacke, DE Singer, GJ Hankey, G Breithardt, KA Fox, RM CaliffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.